Copyright: ©Author(s) 2026.
World J Gastroenterol. Dec 21, 2026; 32(47): 122668
Published online Dec 21, 2026. doi: 10.3748/wjg.122668
Published online Dec 21, 2026. doi: 10.3748/wjg.122668
Figure 1 ZFP36 inhibits cell proliferation, migration, invasion, and facilitates apoptosis in AGS cells.
A: Validation of ZFP36 overexpression efficiency by reverse transcription-quantitative polymerase chain reaction in AGS cells; B: Validation of ZFP36 overexpression efficiency by western blot in AGS cells; C: Cell proliferation assessed by cell counting kit-8 assay; D: Cell cycle distribution analyzed by flow cytometry; E: Cell apoptosis detected by flow cytometry; F: Cell invasion assessed by Transwell assay; G: Cell migration assessed by Transwell assay. aP < 0.05 vs negative control group, bP < 0.01 vs negative control group, cP < 0.001 vs negative control group, dP < 0.0001 vs negative control group. NC: Negative control; OE: Overexpression.
- Citation: Yu PJ, Zhu SM, Cai BJ, Ma XM, Qiao WJ, Han JJ, Zhang CW. Zfp36 zinc finger CCCH-type inhibits gastric cancer progression by upregulating lipase G and binding its 3’ untranslated region. World J Gastroenterol 2026; 32(47): 122668
- URL: https://www.wjgnet.com/1007-9327/full/v32/i47/122668.htm
- DOI: https://dx.doi.org/10.3748/wjg.122668